Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Lindor

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|January 24, 2002
Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosisJulianne Stone, Judy A Wade, Karen Cauch-Dudek, et al.
The American Journal of Gastroenterology|November 15, 2006
Abnormal hepatic biochemistries in patients with inflammatory bowel diseaseFlavia D Mendes, Cynthia Levy, Felicity B Enders, et al.
Annals of Hepatology|April 24, 2014
Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitisJames H Tabibian, Felicity Enders, Mohamad H Imam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysisTej I Mehta, Simcha Weissman, Brian M Fung, et al.
The American Journal of Gastroenterology|January 26, 2005
Mycophenolate mofetil for the treatment of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, Jill C Keach, et al.
Journal of Clinical Gastroenterology|February 1, 2005
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acidJayant A Talwalkar, Paul Angulo, Jill C Keach, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosisMarina G Silveira, Elizabeth M Brunt, Jenny Heathcote, et al.
Journal of Hepatology|May 5, 2004
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?Ahmad S Abdulkarim, Lydia M Petrovic, Woong R Kim, et al.
Journal of Hepatology|December 8, 2004
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver diseasePaul Angulo, Laura M Alba, Lydia M Petrovic, et al.
Gastroenterology|October 20, 2010
Bone disease in patients with primary sclerosing cholangitisPaul Angulo, Garfield A Grandison, Derek G Fong, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|January 24, 2002
Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosisJulianne Stone, Judy A Wade, Karen Cauch-Dudek, et al.
The American Journal of Gastroenterology|November 15, 2006
Abnormal hepatic biochemistries in patients with inflammatory bowel diseaseFlavia D Mendes, Cynthia Levy, Felicity B Enders, et al.
Annals of Hepatology|April 24, 2014
Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitisJames H Tabibian, Felicity Enders, Mohamad H Imam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 5, 2021
Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysisTej I Mehta, Simcha Weissman, Brian M Fung, et al.
The American Journal of Gastroenterology|January 26, 2005
Mycophenolate mofetil for the treatment of primary sclerosing cholangitisJayant A Talwalkar, Paul Angulo, Jill C Keach, et al.
Journal of Clinical Gastroenterology|February 1, 2005
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acidJayant A Talwalkar, Paul Angulo, Jill C Keach, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosisMarina G Silveira, Elizabeth M Brunt, Jenny Heathcote, et al.
Journal of Hepatology|May 5, 2004
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?Ahmad S Abdulkarim, Lydia M Petrovic, Woong R Kim, et al.
Journal of Hepatology|December 8, 2004
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver diseasePaul Angulo, Laura M Alba, Lydia M Petrovic, et al.
Gastroenterology|October 20, 2010
Bone disease in patients with primary sclerosing cholangitisPaul Angulo, Garfield A Grandison, Derek G Fong, et al.
Pageof 27